Mr. Speaker, we still have not been given an answer. Once again, the government has missed the boat.
The Auditor General said that Health Canada does not have a uniform mechanism for monitoring clinical trials of prescription drugs for the most vulnerable, such as children. Other countries receive industry data on adverse drug reactions in children. However, the Conservatives have not bothered with this requirement, which would protect Canadians' health. That is irresponsible.
When will the Minister of Health require pharmaceutical companies to disclose this vital information to protect children who depend on these drugs?